Home › NDC Lookup › RxCUI directory › RxCUI 991082

Dicyclomine hydrochloride 2 MG/ML Oral Solution — RxCUI 991082

RxNorm drug concept · Semantic clinical drug
RxCUI 991082 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 5 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI991082
Official nameDicyclomine hydrochloride 2 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdicyclomine HCl 10 MG per 5 ML Oral Solution; dicyclomine HCl 10 MG in 5 mL Oral Solution
FDA products mapped4
Package NDCs mapped5
Reported Medicaid activity (SDUD)31,499 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dicyclomine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats functional bowel/irritable bowel syndrome. It helps calm the spasms and cramping in your intestines.
  • The capsules, tablets and solution are taken by mouth, generally four times a day. Your prescriber may adjust the amount after a week or so. If you miss a dose, just carry on with...
  • Dry mouth, dizziness and blurred vision are the most common. Nausea, drowsiness, weakness and nervousness can happen too. Be careful driving until you know how it affects you.
  • Call if you feel confused, see or hear things that aren't there, have a racing heartbeat, or can't pass urine. Also call if you overheat without sweating or have diarrhea with a co...
📖 Read our full Dicyclomine guide →

🕸️ Concept Web — How Dicyclomine hydrochloride 2 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dicyclomine hydrochloride 2 MG/ML Oral Solution RxCUI 991082

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Dicyclomine 3361
    • Dicyclomine hydrochloride 152021
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dicyclomine Oral Solution 371815
    • Dicyclomine hydrochloride Oral Solution 2646528
    • Dicyclomine Oral Liquid Product 1151167
    • Dicyclomine Oral Product 1151168
    • Dicyclomine hydrochloride Oral Liquid Product 2662657
    • Dicyclomine hydrochloride Oral Product 2659854
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Dicyclomine hydrochloride 2 MG/ML 991081

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dicyclomine hydrochloride 2 MG/ML SCDC · 991081
  • Dicyclomine Oral Solution SCDF · 371815
  • Dicyclomine hydrochloride Oral Solution SCDFP · 2646528
  • Dicyclomine Oral Liquid Product SCDG · 1151167
  • Dicyclomine Oral Product SCDG · 1151168
  • Dicyclomine hydrochloride Oral Liquid Product SCDGP · 2662657
  • Dicyclomine hydrochloride Oral Product SCDGP · 2659854

📦 FDA Products & Package NDCs

4 products · 5 package NDCs
5 package NDCs map to RxCUI 991082 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-0622-63 473 mL in 1 BOTTLE (0054-0622-63) Dicyclomine Hydrochloride Hikma Pharmaceuticals USA Inc. 2020-05-22
00603-1161-58 473 mL in 1 BOTTLE, PLASTIC (0603-1161-58) dicyclomine hydrochloride Par Health USA, LLC 2005-06-23
17856-2261-01 72 mL in 1 BOX, UNIT-DOSE (17856-2261-1) Dicyclomine Hydrochloride ATLANTIC BIOLOGICALS CORP. 2025-03-04
17856-2261-02 72 mL in 1 BOX, UNIT-DOSE (17856-2261-2) Dicyclomine Hydrochloride ATLANTIC BIOLOGICALS CORP. 2025-03-04
70954-0261-10 473 mL in 1 BOTTLE (70954-261-10) Dicyclomine Hydrochloride Novitium Pharma LLC 2021-04-23
Observed labelers: ATLANTIC BIOLOGICALS CORP. (2) · Hikma Pharmaceuticals USA Inc. (1) · Novitium Pharma LLC (1) · Par Health USA, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.1859
Range $0.1859–$0.1859 · middle 50% $0.1859–$0.1859 · 3 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.